[The characteristics of the reaction of lymphocyte blast transformation using different mitogens in patients with chronic hepatitis].
Lukash. N V NV; Krutikov. S N SN; Ludan. V V VV; Brusilovskiĭ. A I AI
Key Findings
- Thymalin was used as a stimulus to test immune cell (lymphocyte) response.
- Patients with chronic hepatitis showed reduced lymphocyte activity early on.
- Cytometry could detect this reduced activity before obvious symptoms appear.
Practical Outcomes
- For biohackers, the work suggests thymalin might help reveal early immune changes, but it offers no direct dosing or protocol advice for healthy individuals. It’s mainly a diagnostic insight for a specific disease, so its immediate use for longevity or performance is limited.
Summary
The study looked at how a peptide called thymalin affects immune cells in people with chronic hepatitis compared to healthy volunteers. It found that patients with the disease showed early signs of weaker immune cell activity, which could be spotted using a lab test called cytometry. The research doesn’t give clear guidance on using thymalin for health‑boosting in healthy people.
Abstract
Examined were 18 practically healthy subjects and 23 patients with chronic persisting hepatitis. The reaction of blast transformation of leucocytes was carried out in all subjects using PGA and thymalin. The method of cytometry used for evaluation of RBTL permits to reveal at early stages reduction of the functional activity of lymphocytes.
Study Information
pubmed
1991